Polymorphism of rotavirus genotype G1 in Brazil: In silico analysis of variant strains circulating in Rio de Janeiro from 1996 to 2004

Infection, Genetics and Evolution

Volumn 12, Issue 7, 2012, Pages 1397-1404

  Maranhão, Adriana Gonçalves ^a   Vianez Júnior, João Lídio S G ^a   Benati, Fabrício José ^a   Bisch, Paulo Mascarello ^a   Santos, Norma ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Genotyping; Polymorphism; Rotavirus; Vaccine

Indexed keywords

PROTEIN VP7; ROTAVIRUS VACCINE; VIRUS RNA;

ARTICLE; CALCIUM BINDING; CHILD; COMPUTER MODEL; GENE ACTIVITY; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN STRUCTURE; ROTAVIRUS; ROTAVIRUS A; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN; VP7 GENE;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BRAZIL; CAPSID PROTEINS; CHILD, PRESCHOOL; COMPUTER SIMULATION; DIARRHEA; EVOLUTION, MOLECULAR; HUMANS; MASS VACCINATION; MODELS, GENETIC; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; REFERENCE VALUES; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEQUENCE ANALYSIS, DNA;

EID: 84865390624     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.04.018     Document Type: Article

References (46)

1. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
2. Aoki S.T., Settembre E.C., Trask S.D., Greenberg H.B., Harrison S.C., Dormitzer P.R. Structure of rotavirus outer-layer protein VP7 bound with a neutralizing fab. Science 2009, 324:1444-1447.
3. Araújo I.T., Assis R.M., Fialho A.M., Mascarenhas J.D., Heinemann M.B., Leite J.P. Brazilian P[8], G1, P[8], G5, P[8], G9, and P[4], G2 rotavirus strains: nucleotide sequence and phylogenetic analysis. J. Med. Virol. 2007, 79:995-1001.
4. Arista S., Giammanco G.M., de Grazia S., Ramirez S., Lo Biundo C., Colomba C., Cascio A., Martella V. Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population. J. Virol. 2006, 80:10724-10733.
5. Arora R., Chhabra P., Chitambar S.D. Genetic diversity of genotype G1 rotaviruses co-circulating in western India. Vir. Res. 2009, 146:36-40.
6. Arora R., Shobha D., Chitambar D. Full genomic analysis of Indian G1P[8] rotavirus strains. Infect. Genet. Evol. 2011, 11:504-511.
7. Benati F.J., Maranhão A.G., Lima R.S., da Silva R.C., Santos N. Multiple-gene characterization of rotavirus strains: evidence of genetic linkage among VP7, VP4, VP6 and NSP4 encoding genes. J. Med. Virol. 2010, 82:1797-1802.
8. Bishop R.F., Unicomb L.E., Barnes G.L. Epidemiology of rotavirus serotypes in Melbourne, Australia, from 1973 to 1989. J. Clin. Microbiol. 1991, 29:862-868.
9. Ciarlet M., Hoshino Y., Liprandi F. Single point mutations may affect the serotype reactivity of serotype G11 porcine rotavirus strains: a widening spectrum?. J. Virol. 1997, 71:8213-8220.
10. Desselberger U. Genome rearrangements of rotavirus. Adv. Virus Res. 1996, 46:69-95.
11. do Carmo G.M.I., Yen C., Cortes J., Siqueira A.A., de Oliveira W.K., Cortez-Escalante J.J., Lopman B., Flannery B., de Oliveira L.H., Carmo E.H., Patel M. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med. 2011, 8(4):e1001024.
12. Dormitzer P.R., Greenberg H.B., Harrison S.C. Purified recombinant rotavirus VP7 forms soluble, calcium-dependent trimers. Virology 2000, 277:420-428.
13. Dyall-Smith M.L., Lazdins I., Tregear G.W., Holmes I.H. Location of the major antigenic sites involved in rotavirus serotype-specific neutralization. Proc. Natl. Acad. Sci. USA 1986, 83:3465-3468.
14. Estes M., Kapikian A.Z. Rotaviruses. Fields Virology 2007, 1917-1974. Kluwer Healt Lippincott, Williams and Wilkins, Philadelphia, United States. fifth ed. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
15. Eswar N., Marti-Renom M.A., Webb B., Madhusudhan M.S., Eramian D., Shen M., Pieper U., Sali A. Comparative Protein Structure Modeling with MODELLER. Current Protocols in Bioinformatics 2006, John Wiley & Sons, Inc., Supplement 15, 5.6.1-5.6.30.
16. Gouvea V., Brantly M. Is rotavirus a population of reassortants?. Trends Microbiol. 1995, 3:159-162.
17. Gouvea V., Glass R.I., Woods P., Taniguchi K., Clark H.F., Forrester B., Fang Z.Y. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J. Clin. Microbiol. 1990, 28:276-282.
18. Green K.Y., Kapikian A.Z. Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. J. Virol. 1992, 66:548-553.
19. Hoshino Y., Jones R.W., Ross J., Honma S., Santos N., Gentsch J.R., Kapikian A.Z. Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J. Virol. 2004, 78:7795-7802.
20. Iturriza-Gómara M., Isherwood B., Desselberger U., Gray J. Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J. Virol. 2001, 75:3696-3705.
21. Jayasinghe S.M., Palombo E.A. Genetic homogeneity of human serotype G1 rotaviruses isolated during a single epidemic season: implications for vaccine strategies. Acta Virol. 1999, 43:53-55.
22. Jin Q., Ward R.L., Knowlton D.R., Gabbay Y.B., Linhares A.C., Rappaport R., Wood P.A., Glass R.I., Gentsch J.R. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Arch. Virol. 1996, 141:2057-2076.
23. Kapikian A.Z., Simonsen L., Vesikari T., Hoshino Y., Morens D.M., Chanock R.M., La Montagne J.R., Murphy B.R. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. J. Infect. Dis. 2005, 192(Suppl. 1):S22-S29.
24. Kobayashi N., Taniguchi K., Urasawa S. Analysis of the newly identified neutralization epitopes on VP7 of human rotavirus serotype 1. J. Gen. Virol. 1991, 72:117-124.
25. Kumar S., Tamura K., Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform. 2004, 5:150-163.
26. Leite J.P., Carvalho-Costa F.A., Linhares A.C. Group A rotavirus genotypes and the ongoing Brazilian experience: a review. Mem. Inst. Oswaldo Cruz. 2008, 103:745-753.
27. Matthijnssens J., Joelsson D.B., Warakomski D.J., Zhou T., Mathis P.K., van Maanen M.H., Ranheim T.S., Ciarlet M. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology 2010, 403:111-127.
28. Matthijnssens J., Attoui H., Bányai K., Brister J.R., Buesa J., Ciarlet M., Desselberger U., Esona M.D., Estes M.K., Gentsch J.R., Iturriza-Gómara M., Johne R., Kirkwood C., Martella V., Mcdonald S.M., Mertens P.P.C., Nakagomi O., Parreño V., Patton J.T., Rahman M., Ruggeri F.M., Saif L.J., Santos N., Steyer A., Taniguchi K., Van Ranst M. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol. 2011, 156:1397-1413.
29. Maunula L., von Bonsdorff C.H. Frequent reassortments may explain the genetic heterogeneity of rotaviruses: analysis of Finnish rotavirus strains. J. Virol. 2002, 76:11793-11800.
30. Midthun K., Greenberg H.B., Hoshino Y., Kapikian A.Z., Wyatt R.G., Chanock R.M. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J. Virol. 1985, 53:949-954.
31. Nagaoka Y., Tatsumi M., Tsugawa T., Yoto Y., Tsutsumi H. Phylogenetic and computational structural analysis of VP7 gene of group a human rotavirus G1P[8] strains obtained in Sapporo, Japan from 1987 to 2000. J. Med. Virol. 2012, 84:832-838.
32. O'Ryan M., Matson D.O., Estes M.K., Pickering L.K. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J. Infect. Dis. 1994, 169:504-511.
33. Parra G.I., Bok K., Martinez V., Russomando G., Gómez J. Molecular characterization and genetic variation of the VP7 gene of human rotaviruses isolated in Paraguay. J. Med. Virol. 2005, 77:556-579.
34. Parashar U.D., Gibson C.J., Bresee J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg. Infect. Dis. 2006, 2:304-306.
35. Phan T.G., Khamrin P., Quang T.D., Dey S.K., Takanashi S., Okitsu S., Maneekarn N., Ushijima H. Detection and genetic characterization of group A rotavirus strains circulation among children with acute gastroenteritis in Japan. J. Virol. 2007, 81:4646-4653.
36. Rodríguez-Castillo A., González J.E.R., Noriega L.P., Barrón B.L. Analysis of human rotavirus G1P[8] strains by RFLP reveals higher genetic drift in the VP7 than the VP4 gene during a 4-year period in Mexico. J. Virol. Meth. 2006, 138:177-183.
37. Ruiz-Palacios G.M., Pérez-Schael I., Velázquez F.R., Abate H., Breuer T., Clemens S.C., Cheuvart B., Espinoza F., Gillard P., Innis B.L., Cervantes Y., Linhares A.C., López P., Macías-Parra M., Ortega-Barría E., Richardson V., Rivera-Medina D.M., Rivera L., Salinas B., Pavía-Ruz N., Salmerón J., Rüttimann R., Tinoco J.C., Rubio P., Nuñez E., Guerrero M.L., Yarzábal J.P., Damaso S., Tornieporth N., Sáez-Llorens X., Vergara R.F., Vesikari T., Bouckenooghe A., Clemens R., De Vos B., O'Ryan M. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 2006, 354:11-22. Human Rotavirus Vaccine Study Group.
38. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 2005, 15:29-56.
39. Suzuki Y., Gojobori T., Nakagomi O. Intragenic recombination in rotaviruses. FEBS 1998, 427:183-187.
40. Vesikari T., Karvonen A.V., Majuri J., Zeng S.Q., Pang X.L., Kohberger R., Forrest B.D., Hoshino Y., Chanock R.M., Kapikian A.Z. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. J. Infect. Dis. 2006, 194:370-376.
41. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., Dallas M.J., Heyse J.F., Goveia M.G., Black S.B., Shinefield H.R., Christie C.D., Ylitalo S., Itzler R.F., Coia M.L., Onorato M.T., Adeyi B.A., Marshall G.S., Gothefors L., Campens D., Karvonen A., Watt J.P., O'Brien K.L., DiNubile M.J., Clark H.F., Boslego J.W., Offit P.A., Heaton P.M. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 2006, 354:23-33. Rotavirus Efficacy and Safety Trial (REST) Study Team.
42. Ward R.L., Bernstein D.I. Rotarix: a rotavirus vaccine for the world. Clin. Infect. Dis. 2009, 48:222-228.
43. Wiederstein M., Sippl M.J. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007, 35:W407-W410.
44. Wyatt R.G., James H.D., Pittman A.L., Hoshino Y., Greenberg H.B., Kalica A.R., Flores J., Kapikian A.Z. Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J. Clin. Microbiol. 1983, 18:310-317.
45. Xin K.Q., Morikawa S., Fang Z.Y., Mukoyama A., Okuda K., Ushijima H. Genetic variation in VP7 gene of human rotavirus serotype 1 (G1 Type) isolated in Japan and China. Virology 1993, 197:813-816.
46. Zeller M., Patton J.T., Heylen E., De Coster S., Ciarlet M., Van Ranst M., Matthijnssens J. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J. Clin. Microbiol. 2012, 50:966-976.